These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20352235)

  • 1. Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2.
    Klaiber M; Kruse M; Völker K; Schröter J; Feil R; Freichel M; Gerling A; Feil S; Dietrich A; Londoño JE; Baba HA; Abramowitz J; Birnbaumer L; Penninger JM; Pongs O; Kuhn M
    Basic Res Cardiol; 2010 Sep; 105(5):583-95. PubMed ID: 20352235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides-guanylyl cyclase-A signaling in the heart.
    Kinoshita H; Kuwahara K; Nishida M; Jian Z; Rong X; Kiyonaka S; Kuwabara Y; Kurose H; Inoue R; Mori Y; Li Y; Nakagawa Y; Usami S; Fujiwara M; Yamada Y; Minami T; Ueshima K; Nakao K
    Circ Res; 2010 Jun; 106(12):1849-60. PubMed ID: 20448219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
    Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
    Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide-mediated inhibition of microcirculatory endothelial Ca2+ and permeability response to histamine involves cGMP-dependent protein kinase I and TRPC6 channels.
    Chen W; Oberwinkler H; Werner F; Gaßner B; Nakagawa H; Feil R; Hofmann F; Schlossmann J; Dietrich A; Gudermann T; Nishida M; Del Galdo S; Wieland T; Kuhn M
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2121-9. PubMed ID: 23814119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress-dependent dilated cardiomyopathy in mice with cardiomyocyte-restricted inactivation of cyclic GMP-dependent protein kinase I.
    Frantz S; Klaiber M; Baba HA; Oberwinkler H; Völker K; Gaβner B; Bayer B; Abeβer M; Schuh K; Feil R; Hofmann F; Kuhn M
    Eur Heart J; 2013 Apr; 34(16):1233-44. PubMed ID: 22199120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of TRPC6 channels at Thr69 is required for anti-hypertrophic effects of phosphodiesterase 5 inhibition.
    Nishida M; Watanabe K; Sato Y; Nakaya M; Kitajima N; Ide T; Inoue R; Kurose H
    J Biol Chem; 2010 Apr; 285(17):13244-53. PubMed ID: 20177073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger.
    Shah A; Gul R; Yuan K; Gao S; Oh YB; Kim UH; Kim SH
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1365-74. PubMed ID: 20190099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local actions of atrial natriuretic peptide counteract angiotensin II stimulated cardiac remodeling.
    Kilić A; Bubikat A; Gassner B; Baba HA; Kuhn M
    Endocrinology; 2007 Sep; 148(9):4162-9. PubMed ID: 17510245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
    Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cardiac pathway of cyclic GMP-independent signaling of guanylyl cyclase A, the receptor for atrial natriuretic peptide.
    Klaiber M; Dankworth B; Kruse M; Hartmann M; Nikolaev VO; Yang RB; Völker K; Gassner B; Oberwinkler H; Feil R; Freichel M; Groschner K; Skryabin BV; Frantz S; Birnbaumer L; Pongs O; Kuhn M
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18500-5. PubMed ID: 22027011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
    Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
    EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactive adverse mechanical stress responses in dystrophic heart are coupled to transient receptor potential canonical 6 and blocked by cGMP-protein kinase G modulation.
    Seo K; Rainer PP; Lee DI; Hao S; Bedja D; Birnbaumer L; Cingolani OH; Kass DA
    Circ Res; 2014 Feb; 114(5):823-32. PubMed ID: 24449818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of G-protein signaling subtype 4 mediates antihypertrophic effect of locally secreted natriuretic peptides in the heart.
    Tokudome T; Kishimoto I; Horio T; Arai Y; Schwenke DO; Hino J; Okano I; Kawano Y; Kohno M; Miyazato M; Nakao K; Kangawa K
    Circulation; 2008 May; 117(18):2329-39. PubMed ID: 18443239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca
    Shen Z; Zhang Z; Wang X; Yang K
    J Cell Biochem; 2018 Feb; 119(2):1511-1520. PubMed ID: 28771828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
    Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
    Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells.
    Wang Y; Wagner MB; Joyner RW; Kumar R
    Cardiovasc Res; 2000 Nov; 48(2):310-22. PubMed ID: 11054477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
    Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
    Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.